Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Tenax Therapeutics is a clinical-stage pharmaceutical company focused on developing cardiopulmonary therapies. Its primary efforts include advancing levosimendan for pulmonary hypertension in HFpEF patients and exploring imatinib for pulmonary arterial hypertension. The company leverages existing approved drugs with established safety profiles, employing clinical insights and expert-led research to target unmet medical needs in cardiopulmonary diseases. It relies on strategic partnerships, proprietary IP, and regulatory pathways to develop and commercialize innovative treatments.
This description was generated via AI from an annual report. Updated about 1 year ago.